Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The renaissance of complement therapeutics
Daniel Ricklin, Dimitrios C. Mastellos, Edimara S. Reis, et al.
Nature Reviews Nephrology (2017) Vol. 14, Iss. 1, pp. 26-47
Open Access | Times Cited: 339

Showing 1-25 of 339 citing articles:

Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
Luca Perico, Ariela Benigni, Federica Casiraghi, et al.
Nature Reviews Nephrology (2020) Vol. 17, Iss. 1, pp. 46-64
Open Access | Times Cited: 562
Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications
Qing‐zhang Tuo, Shuting Zhang, Peng Lei
Medicinal Research Reviews (2021) Vol. 42, Iss. 1, pp. 259-305
Open Access | Times Cited: 443
Innate immunity in diabetic kidney disease
Sydney C.W. Tang, Wai Han Yiu
Nature Reviews Nephrology (2020) Vol. 16, Iss. 4, pp. 206-222
Closed Access | Times Cited: 392
New insights into the immune functions of complement
Edimara S. Reis, Dimitrios C. Mastellos, George Hajishengallis, et al.
Nature reviews. Immunology (2019) Vol. 19, Iss. 8, pp. 503-516
Open Access | Times Cited: 389
Current understanding of periodontal disease pathogenesis and targets for host‐modulation therapy
George Hajishengallis, Triantafyllos Chavakis, John D. Lambris
Periodontology 2000 (2020) Vol. 84, Iss. 1, pp. 14-34
Open Access | Times Cited: 316
Clinical promise of next-generation complement therapeutics
Dimitrios C. Mastellos, Daniel Ricklin, John D. Lambris
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 9, pp. 707-729
Open Access | Times Cited: 292
Context-dependent roles of complement in cancer
Lubka T. Roumenina, Marie V. Daugan, Florent Petitprez, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 12, pp. 698-715
Open Access | Times Cited: 283
Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
Mohamed A. Alfaleh, Hashem O. Alsaab, Ahmad Bakur Mahmoud, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 213
The complement system in age-related macular degeneration
Angela Armento, Marius Ueffing, Simon J. Clark
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 10, pp. 4487-4505
Open Access | Times Cited: 185
Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System
Sarah M. Carpanini, Megan Torvell, B. Paul Morgan
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 180
Mechanisms of haemolysis-induced kidney injury
Kristof Van Avondt, Erfan Nur, Sacha Zeerleder
Nature Reviews Nephrology (2019) Vol. 15, Iss. 11, pp. 671-692
Closed Access | Times Cited: 156
COVID‐19: A collision of complement, coagulation and inflammatory pathways
Anoop Chauhan, Laura Wiffen, Thomas Brown
Journal of Thrombosis and Haemostasis (2020) Vol. 18, Iss. 9, pp. 2110-2117
Open Access | Times Cited: 141
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
Peter Garred, Andrea J. Tenner, Tom Eirik Mollnes
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 792-827
Open Access | Times Cited: 133
Complement in human disease: approved and up-and-coming therapeutics
Erin E. West, Trent M. Woodruff, Véronique Frémeaux‐Bacchi, et al.
The Lancet (2023) Vol. 403, Iss. 10424, pp. 392-405
Open Access | Times Cited: 58
Investigating the Dynamic Interplay Between Cellular Immunity and Tumor Cells in the Fight Against Cancer: An Updated Comprehensive Review
Seyed Ali Aghapour, Mehdi Torabizadeh, Seyed Sobhan Bahreiny, et al.
Iranian Journal of Blood and Cancer (2024) Vol. 16, Iss. 2, pp. 84-101
Closed Access | Times Cited: 29
Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications
Dani A. C. Heesterbeek, Mathieu L. Angelier, R. A. Harrison, et al.
Journal of Innate Immunity (2018) Vol. 10, Iss. 5-6, pp. 455-464
Open Access | Times Cited: 154
Compendium of current complement therapeutics
Wioleta M. Zelek, Long Xie, B. Paul Morgan, et al.
Molecular Immunology (2019) Vol. 114, pp. 341-352
Open Access | Times Cited: 139
The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy
Dana V. Rizk, Nicolas Maillard, Bruce A. Julian, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 132
Engineered Protein Scaffolds as Next-Generation Therapeutics
Michaela Gebauer, Arne Skerra
The Annual Review of Pharmacology and Toxicology (2020) Vol. 60, Iss. 1, pp. 391-415
Closed Access | Times Cited: 129
The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity
Xaria X. Li, John D. Lee, Claudia Kemper, et al.
The Journal of Immunology (2019) Vol. 202, Iss. 12, pp. 3339-3348
Open Access | Times Cited: 126
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Sigbjørn Berentsen
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 119
The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System
Oskar Eriksson, Camilla Mohlin, Bo Nilsson, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 110
Immunotherapy in sepsis - brake or accelerate?
Folkert Steinhagen, Susanne V. Schmidt, Jens‐Christian Schewe, et al.
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107476-107476
Open Access | Times Cited: 109
Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab
Kioa L. Wijnsma, Rob ter Heine, Dirk Jan A. R. Moes, et al.
Clinical Pharmacokinetics (2019) Vol. 58, Iss. 7, pp. 859-874
Open Access | Times Cited: 106
Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer
Emily K. Kleczko, Jeff Kwak, Erin L. Schenk, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 104
Page 1 - Next Page

Scroll to top